Share Prices & Company Research

Stockbroking

Abcam

Current Price 1174.90p Bid 1173.00p Ask 1174.00p Change 0.09%
Last Updated: 21/09/2019 20:43. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Abcam plc is an innovator in reagents and tools. Abcam's purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Group offers highly validated biological binders and assays to address important targets in critical biological pathways. Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use Abcam's antibodies and affinity binders, reagents, biomarkers and assays and the Group's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.

Financial Highlights Year Ended 30/06/2019

Turnover
£59.90m
Operating Profit
£56.10m
Dividend Yield
1.04
Dividend Per Share
12.13
Dividend Cover
1.81
P/E Ratio
53.27

Key Personnel

Alan Thomas Hirzel
Chief Executive Officer
Gavin Hilary James Wood
Chief Financial Officer
Dr Jonathan Simon Milner
Executive Dep Chairman
Peter Vance Allen
Non-Executive Chairman
Mara Glickman Aspinall
Non-Executive Director
Giles Francis Bertram Kerr
Non-Executive Director
Lady Louise Alexandra Virginia Charlotte Patten of Wincanton
Non-Executive Director
Susan Elizabeth Harris
Non-Executive Director

Stock Details

EPIC
ABC
ISIN
GB00B6774699
Shares in Issue
205,736,276
Market cap
£2,411.23m
Sector

Analyst Views (2)

Strong Buy
 
0.00%
Buy
 
50.00%
Hold
 
50.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
1173.00p
Bid Price
1173.00p
Ask Price
1174.00p
Volume
512220
Change Today
1.00p
% Change Today
0.09%
Open
1191.00p
Previous Close
1173.00p
Intraday High
1192.00p
Intraday Low
1168.00p
52 Week High
1523.00p
52 Week Low
1006.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Abcam Intra-day Chart

Abcam News

News in this section is provided by AJ Bell

Director Deals - Abcam PLC (ABC) 16 Sep 2019 | 12:10 Broker Forecast - JP Morgan Cazenove issues a broker note on Abcam PLC 16 Sep 2019 | 10:00 Director Deals - Abcam PLC (ABC) 11 Sep 2019 | 11:35 Director Deals - Abcam PLC (ABC) 11 Sep 2019 | 11:35 Director Deals - Abcam PLC (ABC) 11 Sep 2019 | 11:35 Director Deals - Abcam PLC (ABC) 11 Sep 2019 | 11:30 Director Deals - Abcam PLC (ABC) 11 Sep 2019 | 11:30 Director Deals - Abcam PLC (ABC) 11 Sep 2019 | 09:00 Broker Forecast - Peel Hunt issues a broker note on Abcam PLC 09 Sep 2019 | 09:40 Abcam profit suffers hit from costs of transition to cloud-based ERP system 09 Sep 2019 | 08:38 Abcam sees annual revenue growing 11% amid strong performance in China 22 Jul 2019 | 08:32 Broker Forecast - Peel Hunt issues a broker note on Abcam PLC 22 Jul 2019 | 08:30 Abcam acquires cell line and lysates portfolio from EdiGene 16 Jul 2019 | 09:53 Broker Forecast - Peel Hunt issues a broker note on Abcam PLC 27 Jun 2019 | 08:50 Broker Forecast - Berenberg issues a broker note on Abcam PLC 25 Mar 2019 | 10:40 Abcam acquires Calico Biolabs 28 Jan 2019 | 07:21 Broker Forecast - Peel Hunt issues a broker note on Abcam PLC 09 Jan 2019 | 08:50 Abcam on track to deliver double-digit revenue growth 08 Jan 2019 | 09:43 Director Deals - Abcam PLC (ABC) 06 Dec 2018 | 14:15 Director Deals - Abcam PLC (ABC) 12 Nov 2018 | 17:05 Director Deals - Abcam PLC (ABC) 12 Nov 2018 | 17:05 Director Deals - Abcam PLC (ABC) 09 Oct 2018 | 11:50 Director Deals - Abcam PLC (ABC) 02 Oct 2018 | 14:25

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Tangible Assets
37.1
25.1
Intangible Assets & Goodwill
227.6
220.5
Investments & Other Non-Current Assets
10.2
9.3
Total Non-Current Assets
274.9
254.9
Inventory
36.0
29.6
Trade & Receivables
43.1
39.3
Cash & Receivables
87.1
90.2
Other Current Assets & Assets Held for Resale
5.6
0.8
Total Assets
446.7
414.8

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Short Term Liabilities
45.3
49.0
Long Term Liabilities
16.6
14.1
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
61.9
63.1

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Net Assets
384.8
351.7

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Share Capital
0.4
0.4
Minority Interests
0.0
0.0
Retained Earnings
260.1
234.4
Share Premium Account
27.0
25.6
Other Equity
97.3
91.3
Total Equity
384.8
351.7

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Cashflow from Operating Activities
70.2
63.3
Cashflow Before Financing
20.3
25.6
Increase / Decrease in Cash
-4.4
5.0

Income (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Turnover
59.9
233.2
Cost of Sales
76.7
70.2
Gross Profit
-16.8
163.0
Operating Profit
56.1
68.8
Pre-Tax Profit
56.4
69.1
Profit / Loss for the Year
45.0
62.2

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
H2 Dividend
07 Nov 2019
29 Nov 2019
H1 Dividend
14 Mar 2019
12 Apr 2019
H2 Dividend
08 Nov 2018
30 Nov 2018
H1 Dividend
15 Mar 2018
12 Apr 2018
H2 Dividend
16 Nov 2017
08 Dec 2017
H1 Dividend
16 Mar 2017
13 Apr 2017
H2 Dividend
10 Nov 2016
02 Dec 2016
H1 Dividend
17 Mar 2016
15 Apr 2016
H2 Dividend
12 Nov 2015
04 Dec 2015
H1 Dividend
19 Mar 2015
17 Apr 2015
H2 Dividend
06 Nov 2014
28 Nov 2014
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.